ACAT2 and human hepatic cholesterol metabolism: Identification of important gender-related differences in normolipidemic, non-obese Chinese patients

Atherosclerosis

Volumn 207, Issue 1, 2009, Pages 266-271

  Parini, Paolo ^a   Jiang, Zhao Yan ^a,b,c   Einarsson, Curt ^c   Eggertsen, Gösta ^a   Zhang, Sheng Dao ^b   Rudel, Lawrence L ^d   Han, Tian Quan ^b   Eriksson, Mats ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

ACAT2; Cholesteryl ester; Gender; HDL; Liver

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE 2; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GALLSTONE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEX DIFFERENCE;

ADULT; APOLIPOPROTEIN A-I; ASIAN CONTINENTAL ANCESTRY GROUP; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL MARKERS; BIOPSY; BODY MASS INDEX; CASE-CONTROL STUDIES; CHINA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GALLSTONES; HUMANS; LIVER; MALE; MICROSOMES, LIVER; MIDDLE AGED; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS B; SEX FACTORS; STEROL O-ACYLTRANSFERASE; TRIGLYCERIDES;

EID: 70350761428     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.04.010     Document Type: Article

References (34)

1. Rudel L.L., Lee R.G., and Parini P. ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia. Arterioscler Thromb Vasc Biol 25 (2005) 1112-1118
2. Parini P., Davis M., Lada A.T., et al. ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver. Circulation 110 (2004) 2017-2023
3. Lee R.G., Shah R., Sawyer J.K., Hamilton R.L., Parks J.S., and Rudel L.L. ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice. J Lipid Res 46 (2005) 1205-1212
4. Lee R.G., Kelley K.L., Sawyer J.K., Farese Jr. R.V., Parks J.S., and Rudel L.L. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential. Circ Res 95 (2004) 998-1004
5. Repa J.J., Buhman K.K., Farese Jr. R.V., Dietschy J.M., and Turley S.D. ACAT2 deficiency limits cholesterol absorption in the cholesterol-fed mouse: impact on hepatic cholesterol homeostasis. Hepatology 40 (2004) 1088-1097
6. Rudel L.L., Davis M., Sawyer J., Shah R., and Wallace J. Primates highly responsive to dietary cholesterol up-regulate hepatic ACAT2, and less responsive primates do not. J Biol Chem 277 (2002) 31401-31406
7. Anderson R.A., Joyce C., Davis M., et al. Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J Biol Chem 273 (1998) 26747-26754
8. Lee R.G., Willingham M.C., Davis M.A., Skinner K.A., and Rudel L.L. Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates. J Lipid Res 41 (2000) 1991-2001
9. Willner E.L., Tow B., Buhman K.K., et al. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 100 (2003) 1262-1267
10. Buhman K.K., Accad M., Novak S., et al. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med 6 (2000) 1341-1347
11. Brown J.M., Bell III T.A., Alger H.M., et al. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss. J Biol Chem 283 (2008) 10522-10534
12. Plosch T., Kok T., Bloks V.W., et al. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J Biol Chem 277 (2002) 33870-33877
13. Jiang Z.Y., Parini P., Eggertsen G., et al. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients. J Lipid Res 49 (2008) 464-472
14. Reihner E., Angelin B., Bjorkhem I., and Einarsson K. Hepatic cholesterol metabolism in cholesterol gallstone disease. J Lipid Res 32 (1991) 469-475
15. Schaffer R., Sniegoski L.T., Welch M.J., et al. Comparison of two isotope dilution/mass spectrometric methods for determination of total serum cholesterol. Clin Chem 28 (1982) 5-8
16. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
17. Carr T.P., Parks J.S., and Rudel L.L. Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis. Arterioscler Thromb 12 (1992) 1274-1283
18. Lada A.T., Davis M., Kent C., et al. Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness. J Lipid Res 45 (2004) 378-386
19. Bell III T.A., Kelley K., Wilson M.D., Sawyer J.K., and Rudel L.L. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice. Arterioscler Thromb Vasc Biol 27 (2007) 1396-1402
20. Ma J., Folsom A.R., Lewis L., and Eckfeldt J.H. Relation of plasma phospholipid and cholesterol ester fatty acid composition to carotid artery intima-media thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 65 (1997) 551-559
21. Warensjo E., Sundstrom J., Vessby B., Cederholm T., and Riserus U. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am J Clin Nutr 88 (2008) 203-209
22. Chambless L., Keil U., Dobson A., et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational monitoring of trends and determinants in cardiovascular disease. Circulation 96 (1997) 3849-3859
23. Wu Y. Current status of major cardiovascular risk factors in Chinese populations and their trends in the past two decades. The Collaborative Study Group on Trends of Cardiovascular Disease in China and Preventive Strategy. Zhong Hua Xin Xue Guan Bing Za Zhi 29 (2001) 74-79
24. Zhang M., Li J., Cai Y.M., et al. A risk-predictive score for cardiogenic shock after acute myocardial infarction in Chinese patients. Clin Cardiol 30 (2007) 171-176
25. Oram J.F., and Vaughan A.M. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Curr Opin Lipidol 11 (2000) 253-260
26. Timmins J.M., Lee J.Y., Boudyguina E., et al. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest 115 (2005) 1333-1342
27. Einarsson K., Hellstrom K., and Kallner M. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia. J Clin Invest 54 (1974) 1301-1311
28. Gälman C., Angelin B., Thorsson B., Bröijersen A., and Rudling M. Bile acid synthesis in man relates to plasma triglycerides, gender and presence of gallbladder but not to aging. Falk Symposium, vol. 165 (2008) A21
29. Scallen T.J., and Sanghvi A. Regulation of three key enzymes in cholesterol metabolism by phosphorylation/dephosphorylation. Proc Natl Acad Sci U S A 80 (1983) 2477-2480
30. Gavey K.L., Trujillo D.L., and Scallen T.J. Evidence for phosphorylation/dephosphorylation of rat liver acyl-CoA:cholesterol acyltransferase. Proc Natl Acad Sci U S A 80 (1983) 2171-2174
31. Bell III T.A., Brown J.M., Graham M.J., Lemonidis K.M., Crooke R.M., and Rudel L.L. Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol 26 (2006) 1814-1820
32. Magkos F., Patterson B.W., Mohammed B.S., Klein S., and Mittendorfer B. Women produce fewer but triglyceride-richer very low-density lipoproteins than men. J Clin Endocrinol Metab 92 (2007) 1311-1318
33. Du S., Lu B., Zhai F., and Popkin B.M. A new stage of the nutrition transition in China. Public Health Nutr 5 (2002) 169-174
34. Mattisson I., Wirfalt E., Andren C., Gullberg B., and Berglund G. Dietary fat intake-food sources and dietary correlates in the Malmo Diet and Cancer cohort. Public Health Nutr 6 (2003) 559-569